Henry Gosebruch is Executive Vice President, Chief Strategy Officer
at AbbVie, responsible for corporate strategy, business development
and acquisitions, search and evaluation, alliance management and
Since joining AbbVie in December 2015, Mr. Gosebruch and his team
have completed more than 75 partnering, collaboration, mergers &
acquisitions (M&A) and venture transactions to bolster AbbVie’s
commercial franchises and pipeline of innovative preclinical and
clinical development programs, working closely with AbbVie colleagues globally.
Prior to joining AbbVie, Mr. Gosebruch was Co-Head of J.P. Morgan’s
North American M&A Group based in New York. He worked on numerous
complex M&A transactions involving companies in more than 20 countries.
Mr. Gosebruch serves on the board of Aptinyx. He is also member of
the Advisory Board for the Life Sciences & Management Program at
the University of Pennsylvania. At AbbVie, he is the executive chair
of the Asian Leadership Network Employee Resource Group.